MAR 25, 2019 10:09 AM PDT

Automated Drug Delivery System To Treat Post-Bariatric Hypoglycemia

WRITTEN BY: Nouran Amin

Low blood sugar is an increasing complication of patients who undergone weight-loss surgery known as post-bariatric hypoglycemia (PBH). The condition is characterized by a severe and debilitating low blood sugars after meals and if left untreated can result in seizures, loss of consciousness and death.

Learn more about gastric bypass complications:

Now, new research has developed an automated drug delivery system that can combat and prevent dangerously low blood sugar in weight-loss surgical patients. The research was presented at the 2019 Endocrine Society's annual meeting.

"Currently available treatments are not always effective for severely affected patients," said lead researcher Christopher M. Mulla, M.D. of Joslin Diabetes Center in Boston, Mass.

The automated drug delivery system is similar to an insulin pump and can detect decreasing glucose levels. They system will then deliver the hormone glucagon when levels are low to prevent hypoglycemic events.

"This study demonstrated that our glucagon automated delivery system can detect imminent low blood sugar and deliver a small dose of glucagon, yielding improvements in blood glucose levels after meals and reducing severe hypoglycemia in patients with PBH," Mulla said. "Further research and development of this system will help treat this challenging disease."

Source: Endocrine Society

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 25, 2019
Drug Discovery & Development
NOV 25, 2019
Darobactin: Promising New Drug to Combat Antibiotic Resistance
Every year, around 700,000 people are estimated to die from drug-resistant infections thanks to our overuse of antibiotics both in agriculture and medicine...
DEC 19, 2019
Drug Discovery & Development
DEC 19, 2019
Upcoming Psychedelic Cure for Addiction Derived from African Shrub
Every year, almost 70,000 people die from an overdose in the US. Now, a company called MindMed is testing a compound derived from ibogaine, a West African ...
JAN 23, 2020
Cell & Molecular Biology
JAN 23, 2020
Scientists Engineer Venom-Producing Organoids
Snake venom is also a source of therapeutics, and a potential source of new medicines....
FEB 10, 2020
Cardiology
FEB 10, 2020
Blocking Problem Protein Shows Promise for Preventing Heart Attacks
Over time, atherosclerosis, a disease that causes fatty plaques to build up in the arteries, limits the flow of oxygen-rich blood to vital organs. Often le...
FEB 11, 2020
Cannabis Sciences
FEB 11, 2020
Traffic Light System Best Way to Label Cannabis Edibles
Cannabis products have become increasingly popular. Yet, as they are still relatively new to the market, research has found that most consumers don’t...
FEB 13, 2020
Cell & Molecular Biology
FEB 13, 2020
Study of Early-Onset Parkinson's Reveals Potential Therapeutic
Around 500,000 Americans are diagnosed with Parkinson's disease every year, and the rate of the disease is rising....
Loading Comments...